Login / Signup

Secukinumab promotes engagement of cholecystokinin and its receptor in epidermal keratinocytes of psoriasis patients.

Atsuko FunakoshiToshiharu FujiyamaKazuki TatsunoTakatoshi ShimauchiYoshiki Tokura
Published in: The Journal of dermatology (2020)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • social media
  • peritoneal dialysis
  • wound healing
  • rheumatoid arthritis
  • ankylosing spondylitis
  • patient reported outcomes